This article proposes the Frankenstein Protocol, an integrative theoretical model that redefines clinical death not as an instantaneous and binary event, but as a gradual biological process whose reversibility critically depends on the metabolic and informational state of tissues, especially the central nervous system. It begins from the hypothesis that the drastic reduction of cellular metabolism, or hypometabolism, acts as a modulator of biological time, slowing the molecular degradation cascades associated with ischemia and anoxia and thereby expanding the temporal window for functional reversibility after circulatory arrest (Dirnagl et al., 1999; Dreier et al., 2018).
The model integrates three independent lines of evidence. First, clinical data from the Emergency Preservation and Resuscitation (EPR) protocol demonstrate that the rapid induction of profound hypothermia in patients with traumatic cardiac arrest can preserve tissue viability and extend the time available for reparative interventions, showing that the cessation of circulation does not imply immediate irreversibility (Tisherman et al., 2019). Second, experimental results from the BrainEx paradigm showed partial restoration of circulation, cellular metabolism, and synaptic functions in mammalian brains hours after circulatory death, revealing a dissociation between the loss of global electrical activity and the structural and molecular integrity of neural tissue (Vrselja et al., 2019). These findings support the notion that critical components of neural information may remain preserved beyond traditionally accepted limits.
Finally, the article incorporates natural empirical evidence of extreme tolerance to anoxia, with particular emphasis on the case of saturation diver Chris Lemons, who survived approximately 30 minutes without a breathable oxygen supply in a low-temperature environment, with no detectable neurological deficits. This event suggests that specific environmental conditions, such as accidental hypothermia and systemic metabolic reduction, may significantly delay cerebral ischemic cascades (Bjertnæs et al., 2022; BBC News, 2019).
Based on this convergence of clinical, experimental, and observational evidence, this article argues that clinical death should be understood as a biologically modulable state, in which metabolic preservation and preservation of the informational organization of the neural system constitute the decisive factor for reversibility. The Frankenstein Protocol does not propose unrestricted resuscitation nor guaranteed preservation of personal identity, but establishes a conceptual framework for rethinking the current limits of resuscitation, extreme neuroprotection, and the operational definitions of death in contemporary medicine and bioethics (Bernat, 2013; Truog & Miller, 2008).
Contemporary medicine still operates, to a large extent, with a binary concept of death, in which an individual is considered alive or dead based on specific criteria, such as irreversible cardiorespiratory arrest or complete loss of brain function. Although operationally useful, these criteria excessively simplify a phenomenon that, from a biological point of view, occurs as a progressive process of cellular, molecular, and systemic failure, not as an instantaneous event (Bernat, 2013). This dichotomous approach becomes particularly problematic in light of recent advances in resuscitation, neuroprotection, and metabolic preservation, which demonstrate that the temporary cessation of vital functions does not necessarily imply the immediate loss of biological viability.
In the clinical context, clinical death is traditionally defined by the interruption of spontaneous circulation and respiration, while brain death is based on the irreversible loss of all brain functions, including the brainstem. However, these criteria are essentially functional and do not necessarily coincide with the structural or informational degradation of tissues. Accumulated evidence shows that neural cells and other tissues can maintain metabolic and molecular integrity for significant periods after circulatory arrest, especially when metabolism is reduced by factors such as hypothermia or induced hypometabolism (Dirnagl et al., 1999; Dreier et al., 2018).
This dissociation between functional and biological criteria has led to bioethical and philosophical debates about what truly constitutes the death of a human organism. Bernat (2013) argues that the definition of death should reflect the irreversible loss of integration of the organism as a whole, while Truog and Miller (2008) emphasize that currently used criteria are, in part, normative constructions shaped by clinical, legal, and social needs, and not solely by strict biological limits. These debates become even more relevant in light of experiments and protocols that challenge the notion of immediate irreversibility after cardiac arrest.
In addition to clinical and biological criteria, the concept of informational death is increasingly emerging, especially in the field of neuroscience. This criterion refers to the irreversible loss of the structural and functional organization that supports neural information, including synaptic connectivity, circuit integrity, and molecular patterns associated with memory and functional identity. The partial preservation of these structures, even in the absence of global electrical activity, suggests that brain death may not temporally coincide with the death of the neural information that constitutes it, opening space for an operational redefinition of reversibility after clinical death (Vrselja et al., 2019).
In this context, this work proposes the central hypothesis that biological reversibility is not a binary state, but a continuous gradient strongly dependent on the metabolic level of tissues. The lower the cellular metabolism, the slower the ischemic, inflammatory, and apoptotic cascades responsible for irreversible structural degradation become. Thus, the time available for reparative interventions should not be measured only in chronological minutes, but in terms of effective biological time, which can be modulated by hypometabolic strategies. This perspective provides the conceptual foundation for the Frankenstein Protocol, which seeks to integrate clinical, experimental, and empirical evidence into a unified model for extending reversibility after clinical death.
Clinical death is traditionally described as the moment when cardiorespiratory functions are interrupted, leading to the immediate cessation of oxygen and nutrient supply to tissues. However, from a biological point of view, this event represents only the beginning of a progressive process, not an instantaneous endpoint. Systemic functional failure often precedes cellular structural irreversibility by minutes or hours, especially in neural tissue, which is highly energy-dependent but also presents mechanisms of temporary tolerance to anoxia (Dirnagl et al., 1999).
After circulatory arrest, the absence of oxygen rapidly leads to ATP depletion, compromising energy-dependent ion pumps and triggering a collapse of the neuronal membrane potential. This event marks the beginning of the so-called ischemic cascades, which include excessive glutamate release, uncontrolled calcium influx, production of reactive oxygen species, and activation of inflammatory and apoptotic pathways. It is important to emphasize that these cascades do not occur instantaneously, but evolve over time, creating a variable window of reversibility before irreparable structural damage occurs (Dirnagl et al., 1999).
Neurophysiological studies in humans demonstrate that even after the complete cessation of global electrical activity detectable by electroencephalography, brain tissue is not immediately dead from a cellular point of view. Dreier et al. (2018) described the phenomenon of terminal spreading depolarization, characterized by a slow wave of depolarization that propagates through the human cortex during brain death. This event occurs minutes after electrical functional collapse and marks the critical transition between a potentially reversible state and the beginning of irreversible structural failure of cellular membranes.
The observation of this temporal sequence reinforces the dissociation between functional death and structural death. Loss of consciousness, organized electrical activity, and clinical responsiveness does not immediately equal the destruction of the cellular and molecular structures that support neural function. During this interval, it is still possible to preserve the integrity of membranes, organelles, and synaptic circuits, provided that ischemic cascades are delayed or interrupted by appropriate interventions, such as metabolic reduction or partial restoration of perfusion (Dreier et al., 2018).
Thus, clinical death should be understood as a gradual biological process in which different levels of organization, systemic, cellular, and molecular, collapse at different rates. Irreversibility is not determined by circulatory arrest itself, but by the progression of the biochemical and structural changes that follow it. This perspective breaks with the binary view of death and provides the theoretical basis for strategies that seek to extend the window of reversibility by slowing cellular degradation mechanisms before the threshold of structural irreversibility is crossed.
Cellular metabolism constitutes the critical temporal variable that governs the speed at which biological processes degrade after the interruption of energy supply. Under normal conditions, the structural and functional integrity of cells depends on a continuous flow of ATP to maintain ionic gradients, enzymatic activity, and molecular repair. When this flow is interrupted, as occurs in circulatory arrest, progression toward irreversibility is not determined exclusively by elapsed physical time, but by the residual metabolic rate of tissues (Dirnagl et al., 1999).
This principle makes it possible to distinguish between physical time, measured chronologically in seconds or minutes, and biological time, defined as the effective speed at which destructive biochemical cascades develop. In states of elevated metabolism, a few minutes of ischemia may result in irreversible damage; in contrast, when metabolism is drastically reduced, the same chronological interval may correspond to minimal biological progression. This decoupling between physical time and biological time is a well-documented phenomenon in contexts of hypothermia, hibernation, and deep anesthesia, and constitutes the physiological foundation of modern neuroprotective strategies (Cook et al., 2017).
In clinical practice, therapeutic hypothermia is the most established example of intentional manipulation of metabolism for tissue preservation. The reduction of body temperature decreases the cerebral metabolic rate by approximately 6–8% per degree Celsius, leading to lower oxygen consumption, reduced excitatory glutamate release, attenuation of calcium influx, and suppression of inflammatory and apoptotic pathways. In neurological intensive care units, this approach has been widely used to limit secondary damage after ischemic insults, such as traumatic brain injury and cardiac arrest (Cook et al., 2017).
Meta-analyses and randomized clinical trials in post-cardiac arrest patients have demonstrated that targeted temperature management is associated with improved neurological outcomes, reinforcing the idea that metabolic modulation not only preserves cells, but also preserves functional biological time for therapeutic intervention (Nielsen et al., 2013). Although there are debates regarding the ideal target temperature, current clinical consensus recognizes that controlled metabolic reduction plays a decisive neuroprotective role, especially in the early post-resuscitation phases.
From a theoretical perspective, metabolic reduction can be understood as an active slowing of cellular degradation, delaying the progression of the ischemic cascades described in Section 2.1. By decreasing energy demand, the integrity of membranes, organelles, and synaptic circuits is temporarily preserved, postponing the threshold of structural irreversibility. Thus, metabolism not only sustains life under normal conditions, but also defines the temporal limits of biological reversibility under extreme conditions.
This understanding establishes metabolism as the main regulator of the biological time of death, providing the conceptual basis for more radical strategies of hypometabolism, such as those used in extreme preservation protocols. In the context of the Frankenstein Protocol, the deliberate manipulation of metabolism does not aim to prolong life indefinitely, but to temporarily freeze the dying process, expanding the window in which functional recovery remains biologically possible.
Hypometabolism refers to a physiological state characterized by a global and coordinated reduction in metabolic activity, in which oxygen consumption, ATP production, and bioelectrical activity are significantly decreased without immediate loss of tissue structural integrity. Unlike the pathological metabolic failure observed in uncontrolled ischemia, hypometabolism represents a functional adaptation that allows survival under conditions of limited energy supply (Bjertnæs et al., 2022).
In nature, states of hypometabolism are widely observed in phenomena such as hibernation, torpor, and estivation, in which organisms drastically reduce their basal metabolic rate to survive prolonged periods of energy scarcity. During these states, brain electrical activity, heart rate, and ventilation may reach extremely low levels without resulting in significant structural damage. The complete reversibility of these states after a return to normal conditions demonstrates that metabolic reduction, when organized and systemic, is biologically safe and functional.
In humans, the most relevant manifestation of hypometabolism occurs in hypothermia, whether therapeutic or accidental. The reduction of body temperature induces a proportional decrease in cellular metabolism, slowing enzymatic reactions, reducing excitotoxicity, and attenuating inflammatory responses. Bjertnæs et al. (2022) document several cases of profound accidental hypothermia in which patients experienced prolonged cardiac arrest, with surprisingly preserved neurological recovery after rewarming and resuscitation, reinforcing the notion that the apparent cessation of vital functions can coexist with latent biological viability.
These extreme states gave rise to the concept of suspended animation in emergency medicine and translational research. Conceptually, biological suspension describes a temporary condition in which vital processes are drastically slowed, allowing the organism to withstand critical periods of insult without significant progression toward irreversibility. Unlike traditional clinical death, biological suspension presupposes active metabolic control, even if this control is artificially imposed through physical or pharmacological means (Alam & Rhee, 2007).
From a functional perspective, hypometabolism can be understood as an intermediate state between active life and biological death, in which cellular and molecular organization is preserved despite the suppression of observable systemic functions. This state does not represent the absence of life, but a slowed form of life in which biological time is drastically compressed relative to physical time. Crucially, the defining characteristic of this state is its reversibility, provided that environmental and metabolic conditions are restored before the threshold of irreparable structural damage is crossed.
In the context of the Frankenstein Protocol, hypometabolism is conceived as a central tool for extending reversibility after clinical death. By inducing or maintaining states of biological suspension, it becomes possible to temporarily interrupt the progression of ischemic cascades, preserving both cellular integrity and the informational organization of the neural system. Thus, hypometabolism ceases to be merely an adaptive or therapeutic phenomenon and becomes an organizing principle for redefining the temporal limits of resuscitation and extreme biological preservation.
Natural cases of survival after extreme periods of anoxia provide a valuable empirical perspective on the real limits of human biological reversibility. Although not experimentally controlled, these events function as natural experiments, revealing conditions under which traditional assumptions about irreversibility after respiratory arrest can be questioned. One of the most emblematic examples is the case of saturation diver Chris Lemons, which occurred in 2012 in the North Sea.
During a subsea maintenance operation at approximately 100 meters of depth, Lemons suffered a catastrophic failure in his life-support system after the rupture of his umbilical, which supplied oxygen, heating, and communication. Isolated on the seabed, he remained conscious for only a few minutes before losing responsiveness, remaining without an effective breathable oxygen supply for an estimated period of about 30 minutes (Last Breath, 2019; BBC News, 2019). According to conventional medical parameters, this interval far exceeds the expected time for irreversible brain damage under normothermic conditions.
Despite this, after being rescued and subjected to resuscitation maneuvers, Chris Lemons progressively recovered, presenting no detectable neurological deficits in subsequent clinical evaluations. This unexpected outcome drew the attention of both the medical community and the general public, being widely documented in news reports and in the documentary Last Breath (2019). Although there are no detailed clinical records comparable to those of a controlled hospital study, the consistency of convergent reports reinforces the factual credibility of the event.
The most plausible physiological interpretation of this case involves a combination of extreme environmental conditions and systemic metabolic reduction. The cold water of the North Sea contributed to rapid body heat loss, inducing a state of accidental hypothermia known to significantly reduce cerebral metabolism and oxygen consumption. In addition, saturation diving involves prolonged exposure to high partial pressures of oxygen before the accident, which may have temporarily increased the reserves of dissolved oxygen in the tissues (Bjertnæs et al., 2022).
These combined factors likely delayed the ischemic and excitotoxic cascades normally associated with prolonged anoxia, preserving the structural and functional integrity of neural tissue for a period far beyond what would be expected under normal conditions. The Lemons case therefore concretely illustrates the decoupling between physical time and biological time discussed in Section 2, demonstrating that chronological minutes of anoxia do not necessarily correspond to equivalent progress toward biological irreversibility when metabolism is drastically reduced.
Although this event cannot be generalized or intentionally replicated, it provides natural empirical evidence that human post-anoxic reversibility is more elastic than traditional models suggest. In the context of the Frankenstein Protocol, the Chris Lemons case functions as an observational proof of principle: under specific conditions of extreme hypometabolism, apparent clinical death can coexist with functional preservation of the neural system, expanding the conceptual limits of resuscitation and biological preservation.
Chris Lemons’s survival after an estimated period of approximately 30 minutes without a breathable oxygen supply represents a physiologically extraordinary outcome when analyzed in light of normal parameters of cerebral tolerance to anoxia. The most plausible explanation for this phenomenon does not lie in a single isolated factor, but in the convergence of extreme environmental and physiological conditions that favored metabolic preservation and delayed the progression of irreversible damage cascades.
The first and most decisive factor was profound environmental hypothermia. Exposure to the cold water of the North Sea promoted rapid body heat loss, inducing a state of accidental hypothermia. According to clinical reviews, reduced body temperature is directly associated with a proportional decrease in cerebral metabolism, with reduced oxygen consumption and ATP production (Bjertnæs et al., 2022). This effect reduces neuronal energy demand and slows oxygen-dependent biochemical processes, creating a condition in which brain tissue can tolerate prolonged periods of hypoperfusion without immediate progression toward irreversible structural damage.
In addition to hypothermia, the specific context of saturation diving introduces a second relevant physiological element: previous oxygen saturation under high environmental pressure. During this type of diving, body tissues remain exposed to elevated pressures for long periods, increasing the amount of oxygen dissolved in plasma and other body compartments. Although this reserve is limited, it may provide a transient additional oxygen supply after interruption of the breathable supply, delaying the onset of complete tissue anoxia. This effect, combined with hypothermia-induced metabolic reduction, contributes to the decoupling between physical time and biological time observed in the case.
These conditions had a direct impact on the dynamics of ischemic and inflammatory cascades. Under normothermic conditions, interruption of cerebral blood flow rapidly leads to ATP depletion, collapse of ionic gradients, excessive glutamate release, and calcium influx, culminating in excitotoxicity, oxidative stress, and activation of inflammatory and apoptotic pathways. However, the literature on accidental hypothermia demonstrates that reduced body temperatures significantly attenuate these responses, delaying terminal depolarization and preserving the integrity of cellular membranes for longer periods (Bjertnæs et al., 2022).
The delay of these pathological cascades does not imply absence of damage, but rather a decrease in the speed at which damage progresses. In conceptual terms, what occurs is a compression of biological time: chronological minutes of anoxia correspond to much less molecular and structural progression than would occur under normal metabolic conditions. This mechanism provides a coherent explanation for the preserved neurological recovery observed in Chris Lemons, despite the extreme duration of oxygen deprivation.
In the context of the Frankenstein Protocol, this physiological interpretation reinforces the idea that reversibility after clinical death is strongly dependent on the initial metabolic state and environmental conditions. The case demonstrates that, under profound hypometabolism induced unintentionally, the human neural system can remain structurally and functionally preserved far beyond traditionally assumed limits. Thus, far from being an inexplicable anomaly, the Chris Lemons event aligns with known physiological principles, serving as empirical evidence that metabolic modulation can redefine, even if temporarily, the limits of biological irreversibility.
Emergency Preservation and Resuscitation (EPR) represents, to date, the most extreme and well-documented clinical precedent for the deliberate use of hypometabolism to extend biological reversibility in humans. Developed in the context of trauma medicine, EPR was designed for patients with exsanguinating hemorrhage and imminent or established cardiac arrest, in whom conventional resuscitation methods are insufficient. In these scenarios, the objective of the protocol is not immediate resuscitation, but temporary preservation of the organism in a metabolically reduced state, creating an expanded window for definitive surgical intervention (Tisherman et al., 2019).
The central physiological principle of EPR is the rapid induction of profound hypothermia, usually through the infusion of cold saline directly into the central circulation, reducing body temperature to approximately 10–15 °C within a few minutes. This abrupt temperature drop results in drastic suppression of systemic metabolism, with significant reduction of oxygen consumption, cerebral electrical activity, and the rate of enzymatic reactions. In this state, the organism enters a condition functionally similar to biological suspension, in which the cellular degradation processes associated with ischemia are slowed enough to allow prolonged periods of absent circulation without immediate progression toward irreversible damage (Tisherman et al., 2019).
From a temporal point of view, EPR unequivocally demonstrates that the time available for medical intervention is not fixed, but can be artificially extended through metabolic manipulation. Under normothermic conditions, circulatory arrest rapidly leads to irreversible cellular failure; under EPR, that same chronological interval corresponds to much less biological progression. Thus, the protocol materializes in clinical practice the concept discussed in the previous sections: the slowing of biological time through hypometabolism.
Initial clinical trials and systematic reviews indicate that EPR is technically feasible and biologically plausible, although associated with significant challenges. Preliminary results suggest that some patients submitted to the protocol may be resuscitated after prolonged periods of absent circulation, something that would be considered fatal under conventional conditions. These findings reinforce the notion that clinical death, when accompanied by extreme metabolic preservation, does not necessarily equal irreversible biological death (Tisherman et al., 2019).
However, traditional EPR presents important limitations, both conceptual and practical. First, it is a highly invasive protocol, applicable only in specialized hospital environments and in very specific trauma contexts. Second, the focus of EPR is predominantly systemic, prioritizing global preservation of the organism and maintenance of general tissue viability, without direct attention to the informational preservation of the neural system. Although the brain benefits indirectly from metabolic reduction, the protocol was not originally designed to optimize conservation of synaptic organization, neural connectivity, or other substrates of brain information.
Furthermore, EPR faces limitations related to the maximum safe duration of profound hypothermia, complications associated with rewarming, and individual variability in the response to extreme hypometabolism. These restrictions reinforce that EPR is not a universal solution, but rather a clinical proof of concept that biological reversibility can be extended beyond traditional limits when metabolism is aggressively controlled.
In the context of the Frankenstein Protocol, EPR is interpreted as a fundamental translational milestone: it demonstrates that extreme metabolic suspension is not merely a theoretical abstraction or a phenomenon observed in animals or natural environments, but a clinically implementable strategy in humans. At the same time, its limitations highlight the need for more refined models capable of integrating systemic metabolic preservation with neural informational preservation, expanding not only biological survival, but also the potential for meaningful functional recovery.
Recent advances in experimental neuroscience have directly challenged the assumption that brain death occurs immediately and irreversibly after circulatory arrest. The BrainEx paradigm, developed by Vrselja et al. (2019), represents a milestone in this debate by demonstrating that fundamental components of neural cellular viability can be restored hours after clinical death, provided that adequate metabolic conditions are artificially reestablished.
In the experiment, pig brains were obtained approximately four hours after death by complete circulatory arrest. Using a specially designed extracorporeal system, the authors partially restored cerebral circulation through an oxygenated synthetic perfusate containing nutrients, neuroprotective agents, and blockers of electrical activity. The results demonstrated the resumption of cellular metabolic functions, including oxygen consumption, ATP production, maintenance of membrane integrity, and vascular responses, showing that neural tissue had not reached complete structural irreversibility within an interval traditionally considered fatal (Vrselja et al., 2019).
One of the most conceptually relevant findings of BrainEx was the clear dissociation between global electrical death and structural death. Although recovery of organized cortical electrical activity was not observed, intentionally suppressed for ethical reasons, multiple markers of cellular and synaptic viability remained preserved. This indicates that the prolonged absence of detectable electrical signals, often used as a criterion for brain death, does not necessarily imply immediate destruction of the cellular and molecular structures that support neural function.
This dissociation reinforces the idea that brain death occurs across distinct temporal layers. Global electrical activity and consciousness are rapidly lost after interruption of circulation, while structural degradation of neural cells, synapses, and circuits occurs progressively, strongly depending on metabolic state and environmental conditions. BrainEx demonstrated that even after hours of normothermic ischemia, it is still possible to preserve, and partially restore, fundamental cellular processes, provided that ischemic cascades have not reached the threshold of structural irreversibility (Vrselja et al., 2019).
From a conceptual perspective, these results support the notion of the brain as a partially preservable informational system. Neural information is not reducible to momentary electrical activity, but includes the structural organization of circuits, synaptic integrity, molecular gradients, and cellular architectures that enable future function. The preservation of these substrates, even in the absence of observable electrical activity, suggests that part of the information necessary for functional recovery may remain intact beyond the point traditionally defined as clinical or even brain death.
The scientific communication conducted by Yale News emphasized precisely this aspect, highlighting that BrainEx did not “resurrect brains,” but revealed a biological gray zone between active functional life and definitive structural death. This communication was essential to avoid misinterpretations and reinforce the ethical and experimental nature of the study, while also expanding the scientific and philosophical debate on the real limits of neural reversibility.
In the context of the Frankenstein Protocol, the BrainEx paradigm provides the most direct experimental evidence that clinical death does not automatically coincide with the irreversible loss of neural organization. It complements EPR, which operates at the systemic level, by demonstrating that metabolic preservation directed at neural tissue can maintain critical elements of brain information even after prolonged periods of ischemia. Thus, BrainEx consolidates the theoretical foundation that reversibility after clinical death is conditioned not only by restoration of circulation, but also by active preservation of metabolism and the informational architecture of the brain.
The Frankenstein Protocol is proposed as an integrative theoretical model, not as an immediately applicable clinical procedure, whose objective is to unify evidence from different domains, including hypometabolism physiology, extreme clinical interventions, and controlled neuroscientific experimentation, into a coherent conceptual framework on reversibility after clinical death. This model begins from the principle that death does not occur abruptly, but as a gradual process whose progression can be modulated by the deliberate manipulation of cellular metabolism.
The first pillar of the model is hypometabolism, widely documented in the clinical literature through therapeutic hypothermia. Reviews in neurocritical care demonstrate that reducing body temperature significantly decreases cerebral oxygen consumption, attenuates excitotoxic and inflammatory cascades, and preserves cellular structural integrity after ischemic insults (Cook et al., 2017; Polderman, 2009). These data establish that metabolic slowing not only reduces secondary damage, but also reconfigures the temporal dynamics of biological irreversibility.
The second pillar is Emergency Preservation and Resuscitation (EPR), which translates this principle into the extreme clinical scenario of trauma medicine. EPR demonstrates that rapid induction of profound systemic hypometabolism can maintain tissue viability during prolonged periods of absent circulation, expanding the window for definitive surgical intervention (Tisherman et al., 2019). In the context of the Frankenstein Protocol, EPR functions as a clinical proof of concept that clinical death can be temporarily stabilized when the organism’s global metabolism is drastically reduced.
The third pillar is the BrainEx paradigm, which provides direct experimental evidence that neural cellular viability and fundamental components of brain organization can be restored hours after clinical death, provided that adequate metabolic conditions are artificially reintroduced (Vrselja et al., 2019). BrainEx demonstrates a critical dissociation between the loss of global electrical activity, traditionally associated with brain death, and the irreversible structural degradation of neural tissue. This dissociation is central to the proposed model because it shifts the focus of reversibility from momentary function to structural and informational integrity.
Through the integration of these three axes, the Frankenstein Protocol introduces the concept of “preserved clinical death,” defined as a state in which observable systemic functions are absent or profoundly suppressed, but cellular metabolism and critical structural organization, particularly in the central nervous system, remain below the threshold of irreversibility. In this state, clinical death ceases to be an endpoint and becomes understood as a potentially reversible transitional condition, provided that the progression of degradation cascades is contained.
Central to this definition is the concept of informational preservation as a criterion of biological reversibility. Unlike purely functional criteria, informational preservation refers to the maintenance of the neural architecture underlying future function: membrane integrity, synapses, local and global connectivity, molecular gradients, and circuit organization. BrainEx provides evidence that these substrates can persist even in the absence of detectable electrical activity, while EPR and therapeutic hypothermia demonstrate that hypometabolism can delay their degradation.
Thus, the Frankenstein Protocol proposes a conceptual shift: reversibility after clinical death should not be assessed only by the immediate restoration of vital functions, but by the latent informational viability of the neural system. Death becomes irreversible not when circulation or electrical activity ceases, but when the informational organization necessary for future function is destroyed beyond a critical threshold.
It is important to emphasize that the model does not imply guaranteed preservation of consciousness, personal identity, or autobiographical memory, nor does it propose unrestricted resuscitation of individuals after long periods of clinical death. Its objective is to provide a rigorous theoretical framework for rethinking the current limits of resuscitation, extreme neuroprotection, and the operational definitions of death, opening new directions for research in metabolic and informational preservation.
The proposition that clinical death can be temporarily stabilized through metabolic and informational preservation requires an operational reassessment of the concept of death in contemporary medicine. Historically, death criteria have been defined based on observable functional markers, such as cardiorespiratory arrest or irreversible absence of brain activity, for clinical, legal, and social reasons. However, as discussed throughout this work, clinical and experimental evidence indicates that these markers do not always temporally coincide with the irreversible loss of biological tissue viability (Bernat, 2013).
From a scientific point of view, this dissociation suggests that death is not a punctual event, but a progressive process in which different levels of biological organization collapse at different rates. The Frankenstein Protocol reinforces this view by introducing the concept of preserved clinical death, an intermediate state in which systemic functions are absent, but critical structural and informational integrity, especially in the central nervous system, remains below the threshold of irreversibility. This redefinition does not invalidate current death criteria, but highlights their operational and contingent character, dependent on the technological capabilities available in each historical context (Truog & Miller, 2008).
A central ethical consequence of this perspective is the conceptual separation between biological viability and personal identity. Metabolic and informational preservation of neural tissue does not necessarily imply preservation of consciousness, autobiographical memory, or psychological continuity of the individual. Personal identity, as discussed in philosophical and neuroethical literature, emerges from dynamic patterns of neural activity and functional integration, not merely from the structural integrity of the brain. Thus, a biologically reversible organism may not, in the full sense, be a psychologically recoverable person (Farah, 2015).
This distinction is fundamental to avoid misinterpretations or unrealistic expectations. The Frankenstein Protocol does not propose the guaranteed restoration of the person as a conscious subject, but rather the extension of the biological possibility of functional recovery. Recognizing this difference is essential to preserve central ethical principles, such as respect for human dignity, informed consent, and therapeutic proportionality.
In the field of emergency medicine, the implications are equally significant. Acceptance that biological reversibility can be extended through metabolic control suggests the need to rethink protocols for termination of resuscitation, criteria of therapeutic futility, and allocation of resources in extreme scenarios. At the same time, this perspective imposes clear limits: extreme preservation interventions must be evaluated not only by technical possibility, but also by their risks, potential benefits, and ethical implications within the specific clinical context.
In neuroethics, the findings discussed in this work expand the debate on the limits of human intervention in the brain and on the moral status of partially preserved neural systems. Studies such as BrainEx raised unprecedented questions about the definition of brain death, the permissibility of post-mortem experimentation, and the need for robust ethical safeguards to avoid inadvertent restoration of conscious states (Vrselja et al., 2019). These debates indicate that scientific advancement in neural preservation must move alongside continuous and interdisciplinary ethical reflection.
In summary, the Frankenstein Protocol does not seek to replace existing definitions of death nor prescribe immediate normative changes, but to provoke a critical reassessment informed by science. By highlighting the temporal plasticity of biological reversibility and the centrality of informational preservation, the model contributes to a more refined dialogue between biology, medicine, philosophy, and ethics, which is essential to guide the responsible development of preservation and resuscitation technologies in the future.
The body of evidence analyzed in this work points to a remarkable convergence among extreme natural observations, deliberate clinical interventions, and controlled neuroscientific experimentation, all supporting the hypothesis that biological reversibility after clinical death is broader and more modulable than traditionally assumed. Although they come from distinct and methodologically heterogeneous contexts, these lines of evidence share a common denominator: the centrality of metabolism as a regulator of the biological time of irreversibility.
Natural cases such as that of Chris Lemons demonstrate observationally that specific environmental conditions can induce deep hypometabolism sufficient to preserve neural function after prolonged periods of anoxia. Clinical protocols such as Emergency Preservation and Resuscitation (EPR) show that this same principle can be intentionally and controllably exploited, allowing extension of the time available for medical intervention in extreme trauma scenarios. Finally, the BrainEx paradigm provides the most direct experimental evidence that essential components of cellular viability and neural organization can persist hours after clinical death, revealing a clear dissociation between immediate functional failure and irreversible structural degradation.
The integration of these findings supports the model proposed by the Frankenstein Protocol, in which clinical death is reinterpreted as a potentially stabilizable state, provided that the progression of metabolic and molecular degradation cascades is delayed below a critical threshold. This convergence does not imply methodological equivalence among the evidence, but points to an underlying physiological coherence that transcends the specific context of each study.
Despite its conceptual strength, the model presents important limitations that must be explicitly acknowledged. First, it is a theoretical framework, not a validated clinical protocol. The evidence supporting it ranges from observational reports to controlled experiments in animal models, which requires caution when directly extrapolating to broad human applications. Second, metabolic and informational preservation does not guarantee recovery of consciousness, personal identity, or higher cognitive functions, aspects that remain largely unpredictable even in scenarios of successful resuscitation.
Furthermore, the model does not resolve significant technical challenges, such as the safe limits of profound hypothermia, the risks associated with rewarming, individual heterogeneity in response to hypometabolism, and the difficulty of directly monitoring neural informational preservation in real time. Ethical and logistical questions also remain regarding when and for whom such strategies should be applied, especially in resource-limited environments.
However, recognizing these limitations does not diminish the scientific value of the model; on the contrary, it helps precisely delimit its scope and utility. The Frankenstein Protocol does not propose the elimination of current death criteria nor unrestricted resuscitation, but offers a new conceptual framework to guide future research and refine still-open questions about biological reversibility.
In this sense, the model points to promising directions for investigation. Among them are the development of more precise strategies for inducing and maintaining hypometabolism, the integration between systemic preservation and neural informational preservation, and the creation of biological metrics capable of objectively assessing the degree of residual reversibility after clinical death. Advances in these fields may allow a gradual transition from the theoretical concept to safer and ethically grounded clinical applications.
Ultimately, the main contribution of this discussion is to show that the current limits of resuscitation are not defined exclusively by absolute biological barriers, but also by historically contingent conceptual and technological limitations. By bringing together dispersed evidence under a unified model, the Frankenstein Protocol invites the scientific community to rethink, critically and responsibly, what it means to die and how far biological return may be possible.
The clinical, experimental, and observational data analyzed throughout this work converge on a central observation: controlling cellular metabolism does not directly preserve life, but preserves the biological time of reversibility. Clinical death, traditionally treated as an abrupt and definitive threshold, reveals itself, in light of current evidence, as a dynamic and modulable state whose progression toward irreversibility critically depends on metabolic rate and tissue structural integrity, especially in the central nervous system.
The Frankenstein Protocol, as an integrative theoretical model, demonstrates that hypometabolic strategies, observed in extreme natural contexts, deliberately applied in clinical protocols such as Emergency Preservation and Resuscitation (EPR), and experimentally explored in the BrainEx paradigm, are capable of slowing the molecular and cellular cascades responsible for irreversible degradation. This slowing creates an expanded temporal window in which functional recovery remains biologically possible, even after prolonged cessation of observable vital functions.
One of the main conceptual advances proposed is the distinction between immediate functional death and irreversible structural and informational death. Evidence such as that presented by Vrselja et al. (2019) indicates that the absence of global electrical activity or circulation does not necessarily imply immediate destruction of the cellular and organizational substrates that support future neural function. In this context, informational preservation, understood as the maintenance of synaptic architecture, cellular integrity, and neural circuits, emerges as a more fundamental criterion for biological reversibility than isolated functional markers.
It is important to emphasize that the Frankenstein Protocol does not propose the elimination of current death criteria, nor unrestricted resuscitation or guaranteed restoration of consciousness and personal identity. Its value lies in providing a rigorous conceptual framework that recognizes death as a gradual process conditioned by metabolic and technological factors, and that guides future investigations into the real limits of resuscitation and extreme biological preservation.
Ultimately, the model suggests that contemporary limits of resuscitation are not imposed exclusively by absolute biological barriers, but also by historical, conceptual, and technical constraints. By demonstrating that reversibility can be extended when metabolism and neural information are preserved, the Frankenstein Protocol expands the scientific and ethical horizon of emergency medicine and neuroscience, inviting a cautious, informed, and responsible redefinition of what it means to die and what may still be biologically recoverable after clinical death.
Bernat, J. L. (2013). Contemporary controversies in the definition of death. Progress in Brain Research, 177, 21–31.
https://doi.org/10.1016/B978-0-444-53855-5.00003-1
Truog, R. D., & Miller, F. G. (2008). The dead donor rule and organ transplantation. New England Journal of Medicine, 359(7), 674–675.
https://doi.org/10.1056/NEJMp0805525
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999). Pathobiology of ischemic stroke: an integrated view. Trends in Neurosciences, 22(9), 391–397.
https://doi.org/10.1016/S0166-2236(99)01401-0
Dreier, J. P., et al. (2018). Terminal spreading depolarization and electrical silence in death of human cerebral cortex. Annals of Neurology, 83(2), 295–310.
https://doi.org/10.1002/ana.25147
Cook, D. J., et al. (2017). Therapeutic hypothermia in neurocritical care. Critical Care, 21(1), 1–10.
https://doi.org/10.1186/s13054-017-1803-1
Nielsen, N., et al. (2013). Targeted temperature management at 33°C versus 36°C after cardiac arrest. New England Journal of Medicine, 369(23), 2197–2206.
https://doi.org/10.1056/NEJMoa1310519
Polderman, K. H. (2009). Mechanisms of action, physiological effects, and complications of hypothermia. Critical Care Medicine, 37(7), S186–S202.
https://doi.org/10.1097/CCM.0b013e3181aa5241
Bjertnæs, L. J., et al. (2022). Accidental hypothermia: clinical management and pathophysiology. The Lancet, 399(10329), 364–376.
https://doi.org/10.1016/S0140-6736(21)02347-3
Brown, D. J. A., & Brugger, H. (2012). Accidental hypothermia. New England Journal of Medicine, 367(20), 1930–1938.
https://doi.org/10.1056/NEJMra1114208
Tisherman, S. A., et al. (2019). Emergency preservation and resuscitation for cardiac arrest from trauma. Annals of Surgery, 270(3), 402–410.
https://doi.org/10.1097/SLA.0000000000003412
Alam, H. B., & Rhee, P. (2007). New developments in fluid resuscitation. Surgical Clinics of North America, 87(1), 55–72.
https://doi.org/10.1016/j.suc.2006.09.006
Vrselja, Z., et al. (2019). Restoration of brain circulation and cellular functions hours post-mortem. Nature, 568(7752), 336–343.
https://doi.org/10.1038/s41586-019-1099-1
Farah, M. J. (2015). Neuroethics: the ethical, legal, and societal impact of neuroscience. Annual Review of Psychology, 66, 575–599.
https://doi.org/10.1146/annurev-psych-010814-015154
Parkinson, A., & da Costa, R. (Directors). (2019). Last Breath [Documentary]. United Kingdom.
BBC News. (2019). Diver survives 30 minutes without oxygen after North Sea accident.
People Magazine. (2019). The true story behind Last Breath: How diver Chris Lemons survived without oxygen.